178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

Παρόμοια τεκμήρια

• 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
  ανά: Quanyuan He, κ.ά.
  Έκδοση: (2023-11-01)
• 346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers
  ανά: Amy Hall, κ.ά.
  Έκδοση: (2023-11-01)
• Tumor neoantigens and tumor immunotherapies
  ανά: Wang Jiani, κ.ά.
  Έκδοση: (2024-04-01)
• Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing
  ανά: Meng Jia, κ.ά.
  Έκδοση: (2023-10-01)
• The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy.
  ανά: Mahdi Golkaram, κ.ά.
  Έκδοση: (2020-11-01)